These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18021336)

  • 1. Pharmacokinetic interaction between ketoconazole and praziquantel in healthy volunteers.
    Ridtitid W; Ratsamemonthon K; Mahatthanatrakul W; Wongnawa M
    J Clin Pharm Ther; 2007 Dec; 32(6):585-93. PubMed ID: 18021336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ketoconazole on praziquantel pharmacokinetics and the role of CYP3A4 in the formation of X-OH-praziquantel and not 4-OH-praziquantel.
    Nleya L; Thelingwani R; Li XQ; Cavallin E; Isin E; Nhachi C; Masimirembwa C
    Eur J Clin Pharmacol; 2019 Aug; 75(8):1077-1087. PubMed ID: 31089768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers.
    Ridtitid W; Wongnawa M; Mahatthanatrakul W; Raungsri N; Sunbhanich M
    J Clin Pharm Ther; 2005 Jun; 30(3):285-90. PubMed ID: 15896247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers.
    Mahatthanatrakul W; Sriwiriyajan S; Ridtitid W; Boonleang J; Wongnawa M; Rujimamahasan N; Pipatrattanaseree W
    J Clin Pharm Ther; 2012 Apr; 37(2):221-5. PubMed ID: 21518375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.
    Krishna G; Moton A; Ma L; Savant I; Martinho M; Seiberling M; McLeod J
    Clin Ther; 2009 Feb; 31(2):286-98. PubMed ID: 19302901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers.
    Ridtitid W; Wongnawa M; Mahatthanatrakul W; Punyo J; Sunbhanich M
    Clin Pharmacol Ther; 2002 Nov; 72(5):505-13. PubMed ID: 12426514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of enzyme inhibition on perampanel pharmacokinetics: Why study design matters.
    Gidal BE; Maganti R; Laurenza A; Yang H; Verbel DA; Schuck E; Ferry J
    Epilepsy Res; 2017 Aug; 134():41-48. PubMed ID: 28535410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ketoconazole and rifampicin on the pharmacokinetics of gemigliptin, a dipeptidyl peptidase-IV inhibitor: a crossover drug-drug interaction study in healthy male Korean volunteers.
    Noh YH; Lim HS; Jin SJ; Kim MJ; Kim YH; Sung HR; Choi HY; Bae KS
    Clin Ther; 2012 May; 34(5):1182-94. PubMed ID: 22534255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of CYP3A4 induction/inhibition on the pharmacokinetics of vilazodone in healthy subjects.
    Boinpally R; Gad N; Gupta S; Periclou A
    Clin Ther; 2014 Nov; 36(11):1638-49. PubMed ID: 25236915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic effect of ketoconazole on solifenacin in healthy volunteers.
    Swart PJ; Krauwinkel WJ; Smulders RA; Smith NN
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):33-6. PubMed ID: 16867168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole.
    Harris RZ; Salfi M; Sullivan JT; Padhi D
    Clin Pharmacokinet; 2007; 46(6):495-501. PubMed ID: 17518508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction between ketoconazole and SPP301 in healthy volunteers.
    Dieterle W; Mann J
    Int J Clin Pharmacol Ther; 2006 Jul; 44(7):326-30. PubMed ID: 16961161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampin, a cytochrome P450 3A inducer, decreases plasma concentrations of antipsychotic risperidone in healthy volunteers.
    Mahatthanatrakul W; Nontaput T; Ridtitid W; Wongnawa M; Sunbhanich M
    J Clin Pharm Ther; 2007 Apr; 32(2):161-7. PubMed ID: 17381666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics.
    Lathia C; Lettieri J; Cihon F; Gallentine M; Radtke M; Sundaresan P
    Cancer Chemother Pharmacol; 2006 May; 57(5):685-92. PubMed ID: 16133532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of ketoconazole on ziprasidone pharmacokinetics--a placebo-controlled crossover study in healthy volunteers.
    Miceli JJ; Smith M; Robarge L; Morse T; Laurent A
    Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):71S-76S. PubMed ID: 10771458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cytochrome P450 3A4 inhibition on the pharmacokinetics of docetaxel.
    Engels FK; Ten Tije AJ; Baker SD; Lee CK; Loos WJ; Vulto AG; Verweij J; Sparreboom A
    Clin Pharmacol Ther; 2004 May; 75(5):448-54. PubMed ID: 15116057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of ketoconazole on the pharmacokinetics of a multireceptor tyrosine kinase inhibitor BMS-690514 in healthy participants: assessing the mechanism of the interaction with physiologically-based pharmacokinetic simulations.
    Yang Z; Vakkalagadda B; Shen G; Ahlers CM; Has T; Christopher LJ; Kurland JF; Roongta V; Masson E; Zhang S
    J Clin Pharmacol; 2013 Feb; 53(2):217-27. PubMed ID: 23436267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Cytochrome P450 3A4 Inhibitors-Ketoconazole and Erythromycin-on Bitopertin Pharmacokinetics and Comparison with Physiologically Based Modelling Predictions.
    Boetsch C; Parrott N; Fowler S; Poirier A; Hainzl D; Banken L; Martin-Facklam M; Hofmann C
    Clin Pharmacokinet; 2016 Feb; 55(2):237-47. PubMed ID: 26341813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketoconazole, a cytochrome P450 3A4 inhibitor, markedly increases concentrations of levo-acetyl-alpha-methadol in opioid-naive individuals.
    Moody DE; Walsh SL; Rollins DE; Neff JA; Huang W
    Clin Pharmacol Ther; 2004 Aug; 76(2):154-66. PubMed ID: 15289792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect of food and ketoconazole on the pharmacokinetics of the smoothened inhibitor PF-04449913 in healthy volunteers.
    Shaik MN; LaBadie RR; Rudin D; Levin WJ
    Cancer Chemother Pharmacol; 2014 Aug; 74(2):411-8. PubMed ID: 24944041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.